Screener
Dianthus Therapeutics DNTH Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $5,274 | $9,725 |
| Accrued expenses | 31,125 | 19,452 |
| Current portion of deferred revenue | 1,485 | 1,188 |
| Current portion of operating lease liabilities | 399 | 367 |
| Total current liabilities | 38,283 | 30,732 |
| Deferred revenue | 6,322 | 5,770 |
| Long-term operating lease liabilities | 965 | 1,019 |
| Total liabilities | 45,570 | 37,521 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dianthus Therapeutics's operating lease liabilities (current)?
- Dianthus Therapeutics (DNTH) reported operating lease liabilities (current) of $399K in Q1 2026.
- How has Dianthus Therapeutics's operating lease liabilities (current) changed year-over-year?
- Dianthus Therapeutics's operating lease liabilities (current) increased by 76.5% year-over-year, from $226K to $399K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Dianthus Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude